Pharmafile Logo
Pharmafocus logo
Advanced Search

coronavirus

Showing 15 posts of 362 posts found.

pharmafocus_april_2020_cover

The April 2020 issue of Pharmafocus is available to read free online now!

April 1, 2020
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing COVID-19, UK, US, coronavirus, generic medicines, pharma, rare disease, real world data, real-world data

The latest monthly edition of Pharmafocus, the April 2020 issue, is available to read for free online now! There’s one …

News
0000000_iran

Europe sells Iran medicine, defying US sanctions

April 1, 2020
Research and Development Iran, Iran Sanctions, Iran US, USA, coronavirus

France, Germany and the UK have announced the sale of medicinal goods to Iran, bypassing US sanctions on the country …

News
000_jjjj

Johnson & Johnson selects lead COVID-19 vaccine candidate and targets September Phase I study

March 31, 2020
Manufacturing and Production . Johnson & Johnson, Johnson & Johnson, Vaccine, coronavirus, coronavirus vaccine

Johnson & Johnson announced that it has selected a candidate for a COVID-19 vaccine from potential constructs it has been …

News
000_parliiii

UK social distancing measures making a difference to the spread of COVID-19, government says

March 31, 2020
Manufacturing and Production British Coronavirus, COVID-`9, coronavirus, coronavirus uk

Social distancing measures are slowing down the spread of coronavirus and keeping pressure off the NHS, according to the UK’s …

News
shutterstock_212432119

EUSA Pharma and Ergomed partner to investigate IL-6 targeting in COVID-19 patients with serious respiratory complications

March 31, 2020
Manufacturing and Production, Research and Development COVID-19, Eusa Pharma, coronavirus, ergomed, pharma

Oncology and rare disease firm EUSA Pharma is aiding in the global fight against the novel coronavirus with the launch …

News
hpv_vaccine

Sanofi agrees a second partnership to develop a COVID-19 vaccine

March 30, 2020
Sales and Marketing Vaccine, china coronavirus, coronavirus, coronavirus vaccine

Sanofi has partnered with Translate Bio to develop a novel messenger RNA (mRNA) vaccine for COVID-19 while they are also …

News
flag_of_world_health_organization_at_un_city

WHO launches “historic” multinational study to investigate most promising COVID-19 therapies

March 30, 2020
Research and Development, Sales and Marketing COVID-19, Gilead, coronavirus, pharma, remdesivir

The World Health Organization continues to push forward in the global fight against the novel coronavirus, and has announced the …

News
000000_new_york

Hydroxychloroquine given to 1,100 patients with COVID-19 in New York

March 30, 2020
Sales and Marketing COVID-19, New York, china coronavirus, coronavirus

The malaria drug hydroxychloroquine is being administered to 1,100 patients in New York, which is fast becoming the new epicenter …

News
mesa_biotech_accula

FDA invokes emergency powers to authorise 30-minute, handheld COVID-19 test

March 27, 2020
Medical Communications, Sales and Marketing COVID-19, FDA, Mesa Biotech, US, coronavirus

The FDA invoked Emergency Use Authorization powers to approve a rapid, handheld testing kit for COVID-19 coronavirus cases just days …

News
top_10_image_2

Top Ten most popular articles on Pharmafile.com this week

March 27, 2020
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing COVID-19, coronavirus

The COVID-19 global pandemic continues to dominate the news cycle. The first clinical trial using danoprevir (Ganovo) in treating COVID-19 …

News

Teva donates millions of hydroxychloroquine sulfate tablets, touted by Trump as coronavirus treatment

March 27, 2020
Medical Communications Trump, coronavirus

Teva pharmaceuticals have said they will provide ten million doses of its anti-malaria drug hydroxychloroquine, which President Trump has been …

News
00000_drug_testing_2019

AbbVie won’t defend its patent for Kaletra so it can be made available for coronavirus treatment

March 26, 2020
Business Services COVID-19, Ebola Drug, Wuhan Coronavirus, china coronavirus, coronavirus

AbbVie has announce it will not defend its patent to its HIV therapy Kaletra (lopinavir) so it can be made …

News
000_britsol

FDA approves BMS’ Zeposia in relapsing multiple sclerosis, but COVID-19 will delay its market entry

March 26, 2020
Sales and Marketing Bristol-Myers Squibb, COVID-19, Zeposia, coronavirus, multiple sclerosis, pharma

Bristol-Myers Squibb has secured approval with the FDA for Zeposia (ozanimod) 0.92mg in relapsing forms of multiple sclerosis (RMS), but …

News
00000

FDA will allow doctors to use convalescent plasma to treat critical COVID-19 patients

March 26, 2020
Business Services COVID-19, China, Chinese Coronavirus, Wuhan Coronavirus, coronavirus

The FDA have announced they will allow doctors to use convalescent plasma, collected from people who recovered from COVID-19, to …

News
000000000

Gilead asks FDA to rescind its Orphan Drug status for potential coronavirus treatment following criticism

March 26, 2020
Business Services China, Gilead, Wuhan Coronavirus, china coronavirus, coronavirus

Gilead Sciences has submitted a request for the FDA to rescind its offer of Orphan Drug designation for remdesivir in …

News

Latest content

FDA approves Amgen’s Imdelltra for extensive-stage small cell lung cancer

May 17, 2024

AstraZeneca shares results from phase 3 trial of COVID-19 prevention drug

May 17, 2024

GSK pledges £45m to Fleming Initiative to fight AMR

May 16, 2024

NeuroSense partners with PhaseV on upcoming phase 3 ALS trial

May 16, 2024

AstraZeneca adds new heart failure target through collaboration with BenevolentAI

May 15, 2024